Cite
HARVARD Citation
Tursi, A. et al. (2021). Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients. European journal of gastroenterology & hepatology. 33 (5), pp. 670-679. [Online].